Why Family Health Insurance Plan needs a Timely Re-Evaluation? Ruby Khatun Khatun20 April 2018 9:15 AM ISTIn the day and age of today, a health insurance plan is a must for everyone. Health insurance plans need to be bought not only for adults and senior...
Ayush Drug Advertising Regulation- ASCI now part of regulatory committee Ruby Khatun Khatun19 April 2018 10:30 AM ISTMumbai: Advertising sector watchdog ASCI said it is part of the ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy...
FDA approves Crysvita for rare inherited form of rickets, x-linked hypophosphatemia Ruby Khatun Khatun19 April 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older...
AstraZeneca to invest 90 million dollars in India over next 5 years Ruby Khatun Khatun19 April 2018 10:00 AM ISTNew Delhi: Biopharmaceutical firm AstraZeneca said it will invest USD 90 million (around Rs 590 crore) in India over the next five years.The...
Sanofi in talks to sell generics arm to Advent for 2.4 billion dollar Ruby Khatun Khatun19 April 2018 9:45 AM ISTPARIS: French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent...
Boston Scientific acquires nVision Medical Corp Ruby Khatun Khatun19 April 2018 9:30 AM ISTBoston Scientific announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health.nVision developed the...
USFDA conducts inspection at Cipla's Indore facility Ruby Khatun Khatun18 April 2018 10:45 AM ISTNew Delhi: Drug major Cipla said the US health regulator has conducted an audit at its Indore facility and has not issued any data integrity or repeat...
Glenmark Pharma to begin phase 2b clinical trial of atopic dermatitis drug Ruby Khatun Khatun18 April 2018 10:30 AM ISTNew Delhi: Drug major Glenmark Pharmaceuticals announced the initiation of phase 2b clinical trial of GBR 830, a novel investigational treatment for...
ICICI Lombard frontrunner for Star Health Ruby Khatun Khatun18 April 2018 10:15 AM ISTMumbai: In a race to acquire Star Health, ICICI Lombard General Insurance Co has emerged as the leader edging past the competing consortium of West...
Indian-American doctors want lowering of cost of prescription drugs Ruby Khatun Khatun18 April 2018 10:00 AM ISTWashington: An influential group of India-American physicians has aligned itself with President Donald Trump's agenda to lower the cost of...
Shire sells cancer drugs to Servier for 2.4 billion dollar as Takeda circles Ruby Khatun Khatun18 April 2018 9:45 AM ISTLONDON: Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its...
Survival data boosts Merck's Keytruda lead in lung cancer Ruby Khatun Khatun18 April 2018 9:30 AM ISTNEW YORK/CHICAGO: Merck & Co’s immunotherapy Keytruda plus chemotherapy significantly improved overall survival in newly-diagnosed patients with...
